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TREATING CANCER
IN THE NEXT CENTURY

Juana Figueroa and her son, Rafael, share a quiet moment together at St. Louis'
Ronald McDonald House. The Figueroas are in St. Louis from their home in Peru
seeking treatment for Rafael.
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PROFILES OF THE CHIEFS
A manipulated image from the screen of a revolutionary treatment planning system suggests the
speed with which radiation oncology is moving into the future. The patten's organs ^sp^ed
Tn individual colors, and the operator can manipulate the image for the clearest view. Photograph
by Steve Kohler.
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Lithotriptors
Topic Of
Symposium
The rapidly evolving
science of biliary lithotripsy
—the treatment of gallstones
noninvasively with devices
that fragment the stones
via shock waves—was the
subject of a three-day international symposium in midJuly. The first of its kind,
the symposium was hosted
by Harvard Medical School.
Second generation
lithotriptors, potent gallstone
solvents, and interventional
procedures were the focus
of discussion. Current
knowledge was explored in
detail by a 20-person guest
faculty that included
Mallinckrodt Institute's
Bruce L. McClennan, M.D.
The presentation by
McClennan, "Biliary Lithotripsy: Perspectives of a
Uroradiologist," acquainted
prospective users of the
technology with the physical
basis, clinical techniques, and
initial results of the pioneering work with the Lithostar
done at Mallinckrodt.

Ex-Residents
Return
When James W. Owen,
M.D., finished his residency
at Mallinckrodt Institute of
Radiology five years ago, he
left what had become a group
of close friends to enter
practice in Topeka, Kansas.
St. Louis slipped into the
past, but the memories
created here remained
important.
When the five-year
milestone arrived, Owen
began to imagine a reunion.
Support among his colleagues
from 1982, '83, and '84
proved strong, and the
reunion was organized for
the weekend of September
23 to 25, 1988, complete

Ex-residents returning for
their reunion: (sitting) David
DiSantis and Jill White
Sullivan, and (standing, left
to right) Floyd Scales, Dale
Johnston, Bob Laakman, Jim
McDonald, Jim Weinstein, Jerry
VanDyke, and James Owen.
with a scientific session on
Saturday and a trip to a
Cardinals' baseball game.
Nine former residents
were able to return to St.
Louis for the refresher. Faculty members R. Gilbert Jost,
M.D., and William A. Murphy,
Jr., M.D., sat in on the continuing education session,
and this year's co-chief resident Bruce Bower, M.D.,
led a tour of Mallinckrodt's
newest facilities to bring
the ex-residents up to date.

Murphy Called
on as MRI
Expert

tration (FDA) gathered for
the first time to discuss the
form and future of therapeutic drug trials in arthritis. He detailed the methods
by which MRI might best be
used to test the efficacy and
safety of new arthritis drugs
about to enter testing.
Two weeks later, Murphy
addressed 40 experts gathered to develop an effective
research strategy for diagnostic radiology for the
next three to five years.
Held to aid the National
Institutes of Health and the
National Cancer Institute
with planning, the workshop presented Murphy
with the opportunity to
assist in setting a national
agenda for the future of
musculoskeletal MRI.
Murphy addressed both
major MRI societies as an
invited speaker at the 1988
annual meetings of the
Society of Magnetic Resonance in Medicine (SMRM)
and the Society of Magnetic
Resonance Imaging (SMRI).
Here, too, he discussed the
state of the art and future
of musculoskeletal MRI.
He also serves as an appointee to a three-year term
on the Scientific Program
Committee of the American
Roentgen Ray Society.

The growing importance
of magnetic resonance
imaging (MRI) in the diagnosis and treatment of musculoskeletal conditions and
Mallinckrodt's role as a
leader in the field have
been highlighted recently
by a call for the expertise of
William A. Murphy, Jr., M.D.,
professor of radiology.
On September 29,
Murphy spoke at a conference of pharmaceutical firm
scientists, academicians, and
regulatory scientists from
the Food and Drug AdminisMALLINCKRODT INSTITUTE OF RADIOLOGY
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Grant Funds
DNA Research

Rare Honor To
Barry Siegel

A five-year, $350,000
grant from the National
Cancer Institute will help
Yvonne C. Taylor, Ph.D.,
assistant professor of cancer biology in radiology,
better understand the precise conditions under which
cells fail to recover from
DNA damage produced by
radiation.
Taylor studies potentially
lethal damage (PLD), a class
of cellular damage caused
by radiation which is normally repaired. However,
certain manipulations of
post-irradiation conditions
can cause cells to not recover
from this damage. Although
many agents are known
that can alter PLD recovery, what makes this damage become lethal is not
understood at the molecular level. Taylor's hypothesis is that the conformation
of chromatin (DNA plus
associated proteins)—which
changes throughout the cell
cycle and when cells go
from a dividing to a nondividing state—is a determining factor in recovery
from PLD.
Says Taylor, "If we can
manipulate the appropriate
changes in DNA, then perhaps we can also manipulate the recovery ability of
cells in tumors." By reducing tumor cell recovery, the
effects of radiotherapy
would be enhanced.

The special citation from
the commissioner of the Food
and Drug Administration
(FDA) reads: "For exceptional leadership in influencing the scientific and
regulatory environment of
radiopharmaceutical drug
development, reflecting
unselfish and enthusiastic
commitment to the FDA."
The recipient: Barry A.
Siegel, M.D., director of
Mallinckrodt's Division of
Nuclear Medicine.
Only a very few such
awards are presented each
year, granted at the commissioner's discretion to
those whose contributions
and accomplishments he
chooses to honor. Siegel
says his award was "totally
unexpected," though his
association with the FDA
goes back to 1972 when, as
a resident, he visited there
for two weeks. At that time,
the agency had just taken
over responsibility for
approving all radioactive
drugs from the Atomic
Energy Commission. Faced
with a large influx of new
drug applications, the
administration brought in a
few outside experts to help
review those applications.
Siegel was one of those
called upon. Ever since, he
has been a consultant to
the FDA's Division of Oncology and Radiopharmaceutical Drug Products, traveling
to Washington D.C. several
times each year as an advisor and problem-solver.
During his years of service, Siegel says his two biggest contributions have been
to oversee the development
of guidelines for the clinical
evaluation of radiopharmaceutical drugs and to promote a change in the method
by which instructions and
indications for a drug's use

Barry A. Siegel, M.D.
are adopted. Because of his
influence, the FDA first
began to consider evidence
from the academic literature as a basis for issuing
guidelines regulating radiopharmaceutical use.
In his letter notifying
Siegel of the award, FDA
Commissioner Frank E.
Young, M.D., Ph.D., wrote,
"To be selected for special
recognition should be most
satisfying since accomplishments such as yours impact
the well-being of the public''
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Residents, fellows, and
trainees ofMallinckrodt Institute ofRadiology for 1987-1988
were (front row) Doctors
Jonathan Wiener, Larry D.
Schertz, David A. Thorne, R.
Gilbert Jost, Bruce L. Bower,
Lynn Barrett, Ronald G.
Evens, Gary D. Shackelford,
Scott N. Nadel, John T.
Engels, Amy A. Mosher, V. Marie
Tartar, Steven S. Eilenberg,
Barbara A. Garner, (second
row) Doctors R. Stephen
Surratt, Paul D. Kountz, Jr.,
Charles F. Garvin, Johnson
Liou, Steven L. Solomon, Ted
J. Cardoso, David N. Rabin,
M. Alan Burns, Scott D.
Stevens, Michael R. Schiering,
Jonathan D. Root, David L.
Rifken, Andre S. Strzembosz,
Threasa H. Reiman, (third
row) Doctors R Kim Nelson,
John Clemett, Richard J.
Pacini, Sonke Harms, Howard
C. Hutt, William G. Way, Jr.,
Allan J. Romano, Michael B.
Evert, Dale M. Fletcher,
James S. Newman, Paul L.
Molina, Thomas F. Hirsch,
Thomas C. Winter III, Charles
A. James, Kevin C. Funk, and
Mark A. Perry.

Bagshaw
Reports Study
Results
When renowned radiation oncologist Malcolm A.
Bagshaw, M.D., spoke at
Mallinckrodt Institute of
Radiology on June 24, the
news he had to share was
good. Reporting on his
study of the world's largest
group of prostate cancer
patients, Bagshaw commented that in a particularly successful subgroup,
eighty-six percent of those
treated with radiotherapy
had retained their sexual
potency 15 months after
treatment. Fifty percent
still had erectile potency
seven years later. Conventional surgery almost always
results in impotency, and
even controversial nervesparing surgery can't claim
such success.
Delivering the annual
Probstein Oncology lecture,
Bagshaw detailed his use of
controlled radiation to treat
more than 900 men suffering
prostate cancer in a 30-year
study at Stanford University,
where he heads the medical
center's Department of
Radiation Oncology.
Bagshaw recalled the
anecdote of one of his
patients, a man in his 80s
with a large but localized
carcinoma of the prostate,

who tolerated the treatment
without difficulty and survived for more than 20 years
with no further evidence of
cancer.
A world authority in the
use of linear accelerators
for the treatment of cancer,
Bagshaw was instrumental
in developing radiotherapy
as a curative treatment for
early stage prostatic cancer.
About 90,000 new cases of
the disease are diagnosed
annually, and it is the second leading cause of cancer
deaths in men 55 and older.
The Probstein Oncology
Lecture was established by
Sally and Norman K. Probstein in honor of William
Fair, M.D., former head of
urology at Washington University School of Medicine,
and Carlos Perez, M.D., director of the Radiation Oncology Center at Mallinckrodt.

Brink Named
To Two Posts
One of Mallinckrodt's
chief technologists, Gary S.
Brink, R.T., B.S., FASRT, has
been selected to serve simultaneously on two national
committees for the American
Society of Radiologic Technologists (ASRT), the largest
organization representing
technologists.
Brink has been named a
member of the Resolutions

Committee, in which position
he will help to consider and
format suggestions submitted from the membership at
large. Brink is one of 12
members of the committee
from across the country.
His concurrent reappointment to the Commission
on Professional Development means that Brink will
also serve to review those
resolutions that concern
professional development
and, as its vice-chairman,
help to set the agenda for
the national organization's
policy on that topic.

Evens Named
To ACR Board
Ronald G. Evens, M.D.,
professor and head of the
Institute, has been appointed
to the Board of Chancellors
of the American College of
Radiology (ACR), "one of
the most senior positions in
the profession and definitely an honor," according to
the ACR's Paul Fullagar.
"The position is filled only
by recognized leaders."
The post is more than
honorary, however, since
the board is the governing
body of the ACR, setting
policy for that national
organization on the advice
of the elected council members. Traditionally, members
of the board are reappointed
twice, serving a total term
of three years. A member
may also succeed himself for
a second three-year term.
Concomitantly, Evens
was named to the chairmanship of the ACR's Commission
on Technology Assessment
and Efficacy Studies. The
commission studies new
treatments and technologies,
then develops an official
position for the ACR. In
addition to guiding radiologists, the information is made
available to other medical

MALLINCKRODT INSTITUTE OF RADIOLOGY
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specialties to inform physicians about the efficacy and
application of radiology's
developing techniques. The
commission, which Evens
now leads, consists of at least
one member from each of
radiology's subspecialties.

Lithostar
Approved
After testing at
Mallinckrodt Institute of
Radiology since December of
1986, the Siemens Lithostar
received FDA pre-market
approval as a treatment
device for kidney stones on
September 30. A second
generation lithotriptor that
requires no water bath and
greatly reduces the need for
anesthesia, the Lithostar is
now officially approved for
sale in the U.S.
More than 500 patients
participated in clinical
trials here. According to cochief investigator Bruce L.
McClennan, M.D., professor
of radiology, the Lithostar
is destined to become an
important machine for
treating kidney stones.
An investigational device
exemption (IDE) has also
been granted by the FDA so
that clinical trials can begin
using Lithostar to treat biliary duct stones. Hepatic,
cystic, and common duct
stones all will be treated
with the Lithostar, employing
the same shock generators
used in disintegrating kidney
stones. Shortly after Christmas, Siemens is scheduled
to deliver a new shock generator to be added to the
Lithostar, making it applicable to gallstones as well.

Setting The
Pace
Late in September, the
installation of a new magnetic resonance (MR) scanner
began when the lid was lifted
off the fifth floor and the
magnet was lowered into
place with a large crane.
The new 1.0 Tesla machine
replaces the .5 Tesla machine
that was the first Siemens
unit in this country. With
much improved image quality
and able to produce images
much more quickly, the new
scanner is Siemens' latest
model. According to Chuck
Armstrong of Siemens, the
1.0 Tesla power level makes
the unit capable of many
kinds of studies, both neurological and musculoskeletal.
Joseph K.T. Lee, M.D.,
professor of radiology, who
heads Mallinckrodt's MRI
effort, says the new machine
incorporates many changes
in both hardware and software and employs a new,
more efficient coil design.
As this was written, he
anticipated an eight-week
installation and shakedown
period, with the first
patients expected to be
seen shortly after Thanksgiving, or just about the
time this edition of Focal
Spot is distributed.
Also on the fifth floor, a
new computed tomography
(CT) scanner is now in operation. The Somatom Plus
from Siemens is the first of
its kind in this country and
one of only two operational
in the world.
A developmental
machine for which new
algorithms and software are
still being created, the Plus
first scanned patients in
mid-September. According
to StuartS. Sagel, M.D.,
professor of radiology, the
machine's design incorporates a continuously rotating
scanning ring and detector

array. That design greatly
reduces the interscan time
and, along with other
improvements, produces an
average scan time of one
second per slice. Such
speed reduces problems
related to movement, particularly respiration by the
patient. The scanner samples
data almost simultaneously
from two views, greatly
reducing artifacts.

The magnet for the new
Siemens magnetic resonance
scanner is lowered through the
roof of the fifth floor, guided
by many hands.
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Carol McCarthy, Ph.D, J.D.,
(left); Mrs. Wendell G. Scott;
and Ronald G. Evens, M.D.

AHA President
Sees Policy
Trends
In the opinion of the
president of the American
Hospital Association (AHA),
physicians and other
healthcare workers have a
responsibility not only to
provide quality treatment,
but to serve as advocates of
public policy that insures
"appropriate, accessible
care for all patients."
Delivering the 17th
annual Wendell G. Scott
Lecture on September 12,

Carol McCarthy, Ph.D., J.D.,
painted the big picture of
the state of current health
policy and its effect on clinical outcomes. Payment policies in both the private
sector and through Medicare,
the trend toward more outpatient care, the medically
indigent without insurance
coverage, and demands for
the measurement of care
quality all are areas in
which McCarthy says public
policy is very active.
Anticipating pressure for
more unified payment systems, McCarthy noted that
more than forty percent of
all hospitals will lose money

treating Medicare patients
this year, yet suggested that
the government will assume
a greater measure of longterm costs. The bedrock of
the insurance system "is in
the private sector and
employer-based insurance.
But that bedrock has eroded.
Of the nation's thirty-seven
million uninsured, fifty-three
percent have a full-time, fullyear link to the workplace,"
she said in detailing the
problems she sees. "Perhaps
it is time that all businesses
accept the cost of health
coverage, just as they do
the cost of a minimum
wage, as a societal obligation and a cost of business,''
McCarthy said. She urged
her audience not to ignore
health policy matters in the
interest of the technical
aspects of medicine.
President of the AHA
since June of 1986, McCarthy
previously served as president of the Massachusetts
Hospital Association and in
executive positions with
other hospital organizations.
She holds a law degree and
a doctorate in healthcare
economics. Well versed in
healthcare administration,
planning, and finance, she
is also a contributing editor
to the textbook, Health
Care in the United States.

Article Calls
For Modern
Management
Michael J. Albertina,
R.T., B. A., chief technologist
of operations at Mallinckrodt,
examines modern healthcare
management techniques in
a five-page article published in the June, 1988,
edition of Administrative

Radiology. The article
explores administrative
concepts that have prevailed
in healthcare and the ways
in which they are changing
as the study of personnel
management evolves. Some
of the problems that occur
as technology advances and
the pressures of efficiency
are felt are also treated.
"Effective management,"
Albertina writes, "focuses
on taking into account the
human needs and aspirations of employees.''
Calling on the healthcare
industry at large to accept
more participative forms of
management, Albertina
says, ' 'the administrator
must begin to function as
team leader. He must begin
to rely more on the knowledge, attitudes, and skills of
others than formal authority and control of information to move the hospital
toward desired goals.''

Oncology
Program
Teaches Basics
Basic immunological
concepts, the effects of
ionizing radiation, and cell
population kinetics were
the principal subjects of
instruction during a fulltime oncology clerkship
program offered to firstyear medical students by
Mallinckrodt Institute of
Radiology over the summer.
Students participated in
clinical activities or assisted
with laboratory investigations related to oncology.
This year's group—D. Ross
Dickson, Ahmed F. Ghouri,
Evelyn C. Kase, and Robert
C. Quackenbush—were all
members of the first-year
class at Washington University Medical School.
At season's end, each of
the four gave a presenta-

MALLINCKRODT INSTITUTE OF RADIOLOGY
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tion summing up the 10
weeks' work. An audience
of technologists and physicians filled Scarpellino
Auditorium for the talks.
Joseph R. Simpson, M.D.,
Ph.D., associate professor
of radiology in the Radiation Oncology Center, coordinated the program for the
eighth year.
New Radiation Oncology residents and new fellows at
Mallinckrodt are (front row,
left to right) Doctors Farrokh
Dehdashti, fellow in Nuclear
Medicine; Carol Yates, fellow
in abdominal radiology;
Ronald G. Evens, professor
and head of the Institute;
Elvira Lang, fellow in interventional radiology; Cheryl
Sisler, fellow inpediatric
radiology. (Back row, left to
right) Doctors Martin Keisch,
resident in Radiation Oncology;
Jeff Michalski, resident in
Radiation Oncology; Jerold
Saef, fellow in Nuclear Medicine; Kenneth Lee, fellow in
Nuclear Medicine; Tsuneo
Hirano, fellow in Nuclear
Medicine.
Eleven physicians have been
accepted into the Institute's
residency program in Diagnostic Radiology. They are (front
row, left to right) Doctors
Andrew Landes; Edith Rang;
Ronald G. Evens, professor
and head of the InstituteDixie J. Anderson, residency
program coordinator; William
Horstman; Clint Anderson,
(back row, left to right) Doctors
JohnEngels, chief resident;
Jonathan White; Robert Smith;
Ronald Robinson; Jeffrey
Borders; Jamie Surratt; Clark
West; Mark Mayhle; Bruce
Bower, co-chief resident.
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ALL THE TIME
By Candace O'Connor

Last Christmas, Forrest Becker, a 69-year-old
retired jeweler, knew something was desperately wrong. He felt weak, he couldn't sleep,
he had pains coursing through his legs. Then
his doctor gave him the bad news. The colorectal cancer
he had faced five years earlier was back, this time as
an inoperable mass invading the sacrum, a triangular
pelvic bone at the base of the spine.
With a full course of chemotherapy and radiation
behind him, Becker came to Mallinckrodt Institute of
Radiology seeking specialized help with treatment
complications. He needed more radiation for the tumor
that was pressing hard against the nerves running down
into his legs. But this time, he was only eligible for 14
treatments-half his initial dose-since more might
damage the very nerves that Becker needed to protect.
How to supplement that dose and strike a more
effective blow at his cancerous mass? This summer,
Becker became one of the first three patients treated
on a promising new piece of equipment now helping
to shrink abdominal and pelvic tumors that lie deep
within the body. This machine, the Sigma 60/BSD-2000,
uses the latest technology to administer an ancient,
though still experimental, form of heat treatment caUed
hyperthermia.
Mallinckrodt is currently
one of six U.S. institutions
embarking on a national
study to track the results of BSD2000 therapy Buoyed by hyperthermia's success in fighting
lesions less than four centimeters
deep, doctors are hoping this
new machine can produce similar
results on deep-seated tumors, as
FOCAL SPOT, FALL/WINTER 1988

much as six to 10 centimeters
below the skin.
"Our experience with recurrent superficial tumors shows we
have a tremendous advantage
when we mix hyperthermia with
radiation or chemotherapy," says
Bahman Emami, M.D., professor
of radiology and chief of the
hyperthermia section, who has

written the protocol for this
national study.
"In our institution, we have
achieved sixty to seventy percent
complete eradication," adds
Emami. "So if we heat these
tumors just as well as we heated
the superficial ones, what's
wrong with hoping we'll achieve
the same results?"
Only seven weeks after the
last of his three hyperthermia sessions, Forrest Becker
is sold on the procedure. He's
walking better and gaining weight.
People stop him to remark how
good he looks. Even the 50-minute
drive from Breeze, Illinois, is well
worth it. "I'd drive him three
hours for this treatment "adds his
son, A.G. Becker.
"I haven't felt this well in a
year," says Becker. "I tell everyone at Mallinckrodt that I'm the
best ad they've got."
Another hyperthermia unit,
the BSD-1000 Annular Phased
Array System, was previously used
at Mallinckrodt in cases of inoperable pelvic and abdominal malignancy. In national and institutional studies of cancer patients
treated with this machine, the
results were encouraging when
the tumor was heated to 42 or 43
degrees Celsius for at least 30
minutes. Unfortunately, equipment limitations made this kind
of heating difficult to achieve.
Patient tolerance to the old
equipment was also a problem. "In
sixty percent of the patients we
had local discomfort and pain. In
twenty percent, we had problems
with apprehension," says Emami.
"They were anxious and wanted

\

GETTING BETTER

to get out. They felt exhausted."
At fault was the design of the
machine, which resembled a
large, opaque box. Patients lay
prone on a stretcher, the heating
unit centered over the area of
their tumor. Unable to see in or
out, they felt claustrophobic.

New Technology Design
he BSD Corporation, manufacturer of the old unit,
answered these criticisms
in creating the BSD-2000 successor unit. This time, they housed
heating antennae in a much
smaller, transparent unit which
slides easily over the pelvic
region and allows patient and
doctor to see what is going on.
Coupled to the antennae is a
Forrest Becker: Walking better and gaining weight.

water bag which also adds to the
patient's comfort. At the start of
the treatment, the bag fills with
warm water, which cools as the
heating progresses.
But the major advance comes
in the machine's vastly improved
technology. First, it allows doctors to steer the heat directly to
the tumor, not simply to a cross
section of the body. Second,
through its computer link, it
gives doctors a chance to preplan
the power needed in each of the
machine's eight antennae to get
the necessary heat to the tumor.
These antennae work by
radiating electromagnetic waves
into the patient's body. This lowfrequency radiation—even lower
than that of a microwave ovengenerates an electrical field
which, in turn, creates conductive current that heats the tissue.

"But you need more than
that," says Robert Myerson, M.D.,
Ph.D., assistant professor of radiology, who has been performing
phantom research and treating
patients using this new equipment. You can't simply dump
power into the body; you need to
deposit it in an organized way
where it is needed."

We have a tremendous
advantage when we
mix hyperthermia
with radiation or
chemotherapy.
That's where the steering
comes in. Unlike the earlier unit,
this one allows doctors to adjust
the phase and amplitude of each
pair of antennae. ' 'Ideally, we
would like to satisfy two requirements : to cover the tumor with the
maximum possible electric field
and to spare normal tissue as
much as possible," says Myerson.
While planning their treatment strategy, doctors
glean information from
the patient's CT scan to determine the target point. They also
take measurements of the
patient and enter data in the
computer, together with initial
amplitude and phase estimates.
Using this data, the computer
then prints out a colorful graph
which predicts power distribution over a cross section of the
body. Red is the area of the most
intense heat; blue, the least.
Based on these predictions, doctors may revise their phase and
amplitude estimates.
Several factors complicate
these estimates, Myerson says.
The computer's predictions

10
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assume that the antennae operate independently of each other.
In fact they interact, loaning
power and borrowing it to and
from each other. Doctors need to
correct for this interaction to
achieve the power they need.
Accuracy may also be affected
by such hard-to-predict factors as
patient bloodflow. If power is
deposited in an area with heavy
bloodflow, the patient's body may
dissipate some of this power, and
a lower temperature may result.
On the whole, though, "this
machine does the physics about
as well as any deep hyperthermia
unit can do it," says Myerson.
"We have more control over
power deposition than we ever
had in the past, and we have as
much control over patient comfort as we can get."

The Treatment Session
Taped to the patient during
treatment are four probes
which use the surface electric field to measure power distribution to the tumor area. Three
or four other probes—inserted in
such natural openings as bladder,
rectum, and vagina—monitor tissue temperature. Another one
measures systemic temperature,
while a last one is placed in the
soft tissue near the tumor.
In less than half an hour,
patients reach the 42 or 43
degree temperature and, ideally,
should sustain it for half an hour
or more. They are not anesthetized or medicated; in case they
experience discomfort, they can
quickly say so. Altogether,
several weekly hyperthermia
treatments are usually scheduled
for each patient. "But I'm satisfied if we can get in one successful session," says Myerson. "That
may be enough to do the job."
Not all cancer patients are
eligible for hyperthermia, he cautions. A healthy heart is necessary,
FOCAL SPOT, FALL/WINTER 1988

since this treatment can heat large
blood vessels and accelerate the
pulse rate. Currently limited to
deep-seated pelvic and abdominal cancer, it is not yet available
for tumors of the thorax.
"In our feasibility study, if
we can show that we are able to
deliver the necessary temperature in fifty or sixty percent of
the patients, we will look at
other tumors—ones that have a
low cure rate with conventional
treatment modalities," says
Emami. "Locally advanced prostate, cervix, and bladder are
potentially all here."
Forrest Becker is awaiting the
results of his follow-up CT scan to

Robert J. Myerson, M.D., assistant
professor of radiology in the Radiation
Oncology Center, examines hyperthermia patient Forrest Becker.

see how his tumor looks now. At
the same time, Mallinckrodt
doctors are studying the unit
that treated him to determine
how effective it is in arresting
tumor growth.
The bottom line is this: "We
now have a better means of treating tumors in the depths of the
body," says Emami. "If this
machine performs in the way we
expect it to, it should be a significant advance." □
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IN THE 21st CENTURY
By Suzanne Hagan

P

this. It's the year
A icture
ICt
2000, and you're looking across the desk at your doctor.
Concern is in his eyes. He explains that you have lung
cancer. Within the hour you are whisked to a CT simulator where a series of 60 to 80 images is made. Your doctor
studies the films, analyzing every inch of you on the computer screen. The images are then fed into a computer
programmed with your doctor's plan of therapy. In
minutes, the computer reconstructs your torso, sculpting a colorful picture of your body in three dimensions.
As the picture is completed, the entire volume and area
of your tumor are revealed, as is the volume of the normal tissue surrounding it. Every detail of the tumor can
be seen as your image moves around on the screen.
As a result of this complex image processing, your
doctor and the medical physicist assigned to your case
can tailor a cancer treatment to the special contours and
configurations of your anatomy. The highest possible
dose of radiation can be delivered to the tumor in your
lung without injury to your heart, spinal cord, and
healthy lung tissue. The chances of controlling your
tumor are good, and the probability of side effects from
treatment is minimal. In 1988, such a precise threedimensional treatment planning system for cancer is
being developed at Mallinckrodt Institute.

TREATING CANCER

4 4 1% IW anY cancers are very
sensitive to radia.tion," says Bahman
Emami, M.D., who specializes in
the radiation treatment of cancer
at Mallinckrodt's Radiation
Oncology Center. "Yet there are
important problems we encounter. One problem is to find the
best way to aim the radiation so
as not to miss the tumor and still
spare healthy organs."
Emami, a member of the team
working on the treatment planning research, describes its
advantages: "One of my patients
had a tumor in the chest region
that could not be treated with a
dose as large as I would have liked
because the heart was in the field.
We were forced to treat with a
lower dose to preserve the heart.
If the computer-driven threedimensional system had been
available, I could have used more
scans to work out a treatment plan
that would have taken that patient
to the dose I wanted, still sparing
the heart. It just bothers me."
Currently cancer specialists
plan radiation treatment by
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Radiation oncologists
continue to encounter
the problem of
finding the best way
to aim the radiation
beam without
missing the tumor
and still sparing
healthy tissue.
hand, drawing the target volume
on the CT scans and delineating
the tumor area on the simulatorgenerated X-ray films. Lack of

time and technology limit the
number of CT scans that the doctor can realistically use. These
limitations often compromise
cancer treatment.
Te warvt radiation
therapy delivered
safely and effectively," explains Robert Morton,
director of the Radiation Research

W:
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''We're designing our
systems for cancer
specialists to use, not
for computer
scientists."
Program at the National Cancer
Institute (NCI). "As part of that
effort, we want to know what
dosage is delivered not only to
the tumor, but also to normal tissue nearby." What is needed is a
system that quickly combines the
patient's 60 to 80 CT scans into a
three-dimensional image and the
software for planning and delivering radiation therapy.
Morton's program has funded
six institutions in two separate
contracts—Memorial SloanKettering, Massachusetts General
Hospital, M.D. Anderson Hospital,
University of Michigan, University of Pennsylvania, and Mallinckrodt Institute—to evaluate the
potential of three-dimensional
radiation treatment planning for
several hard-to-treat cancers.
James A. Purdy, Ph.D., a
radiation physicist, is the principal investigator of the two NCI
contracts at Mallinckrodt Institute.
His group used an image processor
developed at Washington University's Biomedical Computer Laboratory for molecular biology. It
was adapted to accept multiple
images from CT scans, displaying

these images on a video screen.
The treatment planning software
combines these "slices," sculpting them into a lifelike threedimensional image. The video
screen also displays a simulation
of the radiation beam impinging
on the treatment area. When the
viewer uses the workstation's joystick, the images can be turned
so that any aspect is visible.
Thus, a physician can accurately
simulate the effects of a planned
pathway of radiation. Such precision has never before been used
in planning radiation therapy.
4 4 f~\ ne thing I particularly
} liked about the St. Louis
group's approach," says
Morton, "is the ability to visualize
the enhancement of the field of
treatment. Their system enables
a viewer to see the field edges
encompassing the tumor and plan
a beam trajectory that avoids as
much of the normal tissue as possible. I think that of all the contracts,
theirs was the best approach."
"We are developing new tools
for radiation treatment," explains
Purdy. "These new tools will better represent the three-dimensionality of the tumor. The X-ray
and radiation beam therapy used
for treatment will better conform
to the tumor's volume. This will
enable us to use higher doses of
radiation to treat the tumor and
control cancers that we previously could not."
Purdy and his co-workers, who
presented their 3-D work at the
American Society for Therapeutic
Radiology and Oncology (ASTRO)
meeting in October, emphasize
that without the data provided
by CT scans, such an approach to
radiation treatment planning and
delivery would not be possible.
However, since the software is
only now becoming available for
combining the images into a
graphic representation of the
patient's anatomy and for provid-

Oi

14
MALLINCKRODT INSTITUTE OF RADIOLOGY

.

ing real time interactivity, a cancer specialist like Emami must do
his treatment planning by hand.
That is, he uses at most two or
three CT scans, MR images, or
standard X-ray images to hand
draw the desired treatment area
where the beam is to be directed.
Then he uses a conventional treatment planning system to compute
the overall dosage theoretically
delivered, typically ignoring tissue
density effects. This estimated
dosage doesn't take into account
the radiation scattering effects
from inhomogeneities within the
treatment area. Nor is there
extensive data to determine the
tolerance of normal tissue to
radiation. Radiation oncologists
have to use their experience to
decide where and how much to
irradiate a patient to kill as much
of the tumor as possible.
The system that Purdy's
group is developing will get
around these difficulties. All
the diagnostic images, not just
two or three, can be used by the
computer to construct an electronic sculpture of the patient's
anatomy, allowing the doctor a
timely way of delineating the
tumor. The computer can calculate the amount of radiation
striking any point within the
tumor volume, taking into
account the scattering effects
from inhomogeneities. Thus, the
total dosage being delivered can
be figured accurately.
Radiation oncologists realize
that their efforts to plan doses,
even with three-dimensional planning, will need new technology
to verify the treatment if the
potential is to be realized. Currently, a weekly X-ray image made
during the course of a patient's
radiotherapy is compared with one
made prior to treatment to decide
if the radiation beam needs to be
adjusted. Ideally, verification
should take place as radiation is

being delivered, not afterward.
John Wong, Ph.D., a member
of Purdy's group, has taken on
this problem. He has developed a
system of plastic fiber optics to
measure radiation passing through
the patient to a fluorescent screen
below. The fiberoptic cables pick

reality, and to do it in such a way
that dedicated workstations are
networked together into a 3-D
radiation therapy system. Eventually, supercomputers will be
available for such applications,
but Purdy's system will definitely
be user friendly: "We're designing our systems for cancer
specialists to use, not computer
scientists,'' he says.
Emami is enthusiastic about
the potential of this new system,
which should be available for
limited clinical use in about three
years: "Right now, if I give a certain patient a particular dose, I
might expect a cure rate of thirtyfive percent. But if I can increase
this dose to twice as much—an

The images produced by the new system
show the body's features in realistic
detail, revealing for study the volume of
the tumor to be treated.

"One of my
patients had a
tumor in the chest
region that could not
be treated with as
high a dose as
I would have liked
because the heart
was in the field.
We were forced to
treat with a lower
dose to preserve
the heart"

up the image from the fluorescent
screen and transmit it to a TV
camera interfaced with a computer workstation. The transmitted image shows whether the
radiation is reaching the desired
area and displays any fluctuations in the beam due to setup
variations and patient motion.
Purdy and his research team
also hope to develop computer programs to control
the radiation beam's direction and
shape, customizing it to allow for
a patient's individual contours and
irregularities. "Rather than treating only rectangular or square
fields," says Purdy, "we will be
able to shape the field. We will
also be able, under computer
control, to move the patient and
the beams simultaneously, allowing us to deliver a much higher
dose to the patient."
Purdy's goal is to develop all
the necessary software to make
these computer innovations a

option I don't have now because
of the limits of the normal tissue
to radiation exposure—then I can
expect a much improved cure
rate." By the year 2000, doctors
hope to be able to offer their
cancer patients a cure rate of
fifty percent. □
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SWING
the

COURSE
The Prolonged Search
for an Effective Radiosensitizer
by Steve Kohler

cientific research doesn't often proceed as
smoothly as its practitioners would like. The big
breakthrough announced in the headlines is the
rare exception; more often, tiny advances are preceeded by years of diligence. As an endeavor, research requires not just insight and precision, but optimism and
hope.
When Tbdd Wasserman, M.D., needs inspiration to
stay the course in his own work, he thinks back to a
childhood experience. At the age of six, he participated
in the clinical trials of the Salk polio vaccine, receiving
three doses of either placebo or active vaccine—at the
time he didn't know which. After many failed attempts
to control polio, the eventual success of those trials
resulted in what Wasserman calls "one of the most
important changes in medicine to occur during my preprofessional lifetime." Then, in an uncharacteristically
personal note, he adds, "It inspired me."
Tbdd H. Wasserman, M.D., and his
patient, Thomas Consiglio, in consultation. Consiglio was apart of the phase I
clinical trials ofSR-2508 and is a vocal
advocate of the drug's promise.

STAYING THE COURSE

These days, Wasserman, professor of radiation oncology
in Mallinckrodt's Radiation
Oncology Center and chief of the
Department of Radiation Oncology at Jewish Hospital, is on the
convoluted trail of improved
treatments for cancer—a more
complicated disease than polio.
Actually, Wasserman points out,
cancer is a whole family of diseases that will always require a
variety of cures and treatments.
Specifically, his work entails
the testing of drugs that will make
cancer cells more vulnerable to the
effects of radiation. Radiation
destroys cells by inducing certain
chemical changes from which they
cannot recover. If those changes
can be enhanced via chemical
manipulation, then radiation's
effects can be magnified.
For 30 years it's been known
that many tumors are organized

The potential for
good is at least as
great as it was in the
case of polio and the
Salk vaccine.
as concentric rings of cells, each
layer identifiable according to its
oxygen content. At the core is
often a dead region, isolated from
both blood supply and oxygen.
At the surface lie active, highly
oxygenated cells that radiation
kills without difficulty. Between
those two is a zone of oxygenpoor, or hypoxic, cells that radiation has difficulty affecting. In a
state akin to dormancy, these
cells can quickly become revitalized and dangerous again should
the overlying cells be stripped
away, as they are during a course
of radiation therapy.
18

Research in the lab has
shown that oxygenating the
hypoxic region of tumors
makes those cells more susceptible to treatment with radiation.
Effectively treating hypoxic cells
may require three times the radiation dosage necessary for treatment in an oxygen-rich setting.
That dose of radiation can be too
much for surrounding normal
tissue to bear. Early attempts to
increase the efficiency of radiation
therapy by increasing oxygen
levels included placing patients
in hyperbaric chambers to force
oxygen deep into their systems.
Cumbersome and impractical,
that approach was abandoned.
But Wasserman and his colleagues recognized that chemical
agents might be able to sensitize
hypoxic cells to radiation, reach

In the laboratory where SR-2508 is
assayed, Todd H. Wasserman, M.D.,
holds a vial of the radiosensitizer he's
worked with for more than five years.

into the dormant zones of tumors,
and yet not sensitize normal tissue. In 1977, clinical trials began
to test the drug misonidazole,
commonly called miso, as a
tumor-cell sensitizer.
A sort of "fool's gold" in Wasserman's explanation, miso does
not actually increase the oxygen
level of hypoxic cells, but it
' 'induces chemical events after
radiation similar to those of oxygen." And it shows a preference
for hypoxic tissues, collecting there
via a mechanism that remains
not totally understood. Apparently, the drug makes it impossible for damage done to the cells'
MALLINCKRODT INSTITUTE OF RADIOLOGY

DNA by radiation to be repaired.
The effected cell dies.
The problem with miso came
during the translation from the
laboratory to the practical world
of treating patients. The drug
could not be tolerated in doses

Wasserman eooplains:
"Good science doesn't
always end in
positive results."
large enough for its effectiveness
to be measured or relied upon.
Therapeutic gain was never
demonstrated; research had not
run smoothly at all.
But the theory continued to
make sense and offer promise. A
derivative of miso—known as
etanidazole or SR-2508-works in
much the same way. Except that
it can be administered in total
doses three times as large as miso
thanks to its lower toxicity. Still
present is the predictable side
effect of a cumulative neuropathy,
a tingling sensation particularly
in the extremities that builds after
several doses have been administered. But the serious mental
confusion that limited the effectiveness of miso is gone. Thankfully, the neuropathy disappears
after the regimen is completed.
According to Norman
Coleman, M.D., chairman
of the Radiation Therapy
Department at Harvard Medical
School, SR-2508 is the first drug
good enough to really test the
hypothesis that cell sensitizers
can increase the efficiency of
radiation therapy in cancer. He
says, "It's true that we have not
succeeded. But we have a much
better drug now."
Wasserman, eager for success
after 14 years of leading the

research, agrees. He says, "We
would not have developed
SR-2508 if miso had been an
immediate success. And this is
probably not the last drug we
will have to develop. But it may
let us know that we have the
right approach."
Not that the work to date has
no value. As Wasserman explains,
"Good science doesn't always end
in positive results. Understandable,
repeatable results, yes. But not
always and every time positive. If
you know more when you're done,
if you answer a question, then it
can be considered successful."
Testing in phase III clinical
trials, in which large numbers of
patients are treated with radiation
and with or without SR-2508,

The serious mental
confusion that limited
the effectiveness of
miso is gone.
began in July, 1987, at 25 North
American institutions, all members of the Radiation Therapy
Oncology Group (RTOG). Twentyfive European cancer centers are
testing SR-2508 simultaneously
in a parallel study. Head and
neck tumors, readily quantifiable, are under study and results
are expected in 1990, just in time
for the Seventh International
Conference on Chemical Modifiers which Wasserman will chair.
He was co-chairman for the sixth
conference held earlier this year
in Paris.
Organizing the research and
bringing investigators
together from around the
world to share their insight has
required extraordinary perseverance. Many negative and null

trials have had to be reported.
Fully half of Wasserman's academic
life has been devoted to the
struggle to bring cell sensitizers
like SR-2508 to their potential. The
results of the trials now being
conducted will be the watershed.
But no matter what those
results are, this research could
hardly have had a more dedicated
captain. From his office at Harvard, Coleman says Wasserman
has been "the engine that has
run it. The research might have
died several times if it hadn't been
for Todd Wasserman. He gets people together; he's skilled in dealing with the National Institutes
of Health, a source of grant money,
and a tremendous facilitator."
Carlos Perez, M.D., director of
the Division of Radiation Oncology at Mallinckrodt, joins in registering his hope for the work.
"The biological basis is very
sound. It works well in the lab.
Even if we don't hit a home run
here, we will still win the game
with small, incremental gains."
The potential for good is at
least as great as it was in the case

Cancer is a whole
family of diseases
that will always
require a variety of
cures and treatments
of polio and the Salk vaccine. So
Todd Wasserman moves along at
the rate that good science will
allow, suffering the frustration of
small victories. He develops and
tests new compounds in blind
trials much like the one he was
involved in 36 years ago when he
received the Salk vaccine that
later erased the menance of polio
for so many. □
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darkness of his St. Louis room.
Xeroderma pigmentosum, a rare skin
disease, restricts his exposure to light.

by Steve Kohler

herever she goes in St. Louis,
Juana Figueroa takes along
two companions. One is her
son, Rafael, whose rare disease has brought the pair here from
their home in Lima, Peru. The other is a small, stout notebook,
its pages listing the names of all those people who have helped
the mother and son on their quest to find treatment for Rafael.
The entries in the book are in chronological order—the most
recent contacts last. At the top of page one is the name of Carlos
A. Perez, M.D. When Mrs. Figueroa and her son got off the plane
from Lima, the only English they knew was the name of Perez
and that of Mallinckrodt Institute of Radiology.
They'd flown for almost 10 hours, courtesy of Eastern Airlines, in the hope that Perez, who directs the Radiation Oncology Center at Mallinckrodt, could provide the extraordinary care
that Rafael requires. Diagnosed at age four as suffering from
xeroderma pigmentosum (a rare pigmentary disease of the skin
that leaves its victims extra-sensitive to the damage wrought
by ultraviolet light), Rafael had seen his condition worsen; eight
years later Lima's specialists could be of little help. More
advanced therapy was required.
Mayer Zaharia, M.D., chief of the Department of Radiation
Therapy at Lima's Institute of Neoplastic Diseases, a huge cancer
hospital, suggested Mallinckrodt Institute. Zaharia had been a
visiting professor here and had seen the successes of Perez and
his colleagues.
W1

J

FOCAL SPOT, FALL/WINTER 1988

21

OUT OF THE DARK

Deplaning on July 7, the
Figueroas—mother and son
—found their way to South
Kingshighway and eventually to
Pat Norton, whose name is entered
second in the little notebook. A
clinical research assistant in
Radiation Oncology with a degree
in Spanish, Norton immediately
assumed the role of mentor to
the visitors. She arranged lodging
and acted as a translator while
Juana's English came back from
her days as a high-school student
of the language.
Specialists were called in. The
name of Ann Martin, M.D., was
inscribed indelibly when she took
over management of the dermatological aspects of Rafael's case.
Otolaryngologists Gershon Spector,
M.D., and Donald Sessions, M.D.,
joined the team when biopsies
revealed that the underlying
xeroderma pigmentosum had led
to a melanoma on Rafael's ear
that required surgery.
Written large in the book is
the name of Karen Forsman, M.D.,
a resident in dermatology who has
acted to coordinate the therapy
and all the contributing specialists.
Among those whose expertise
she has called upon is Fred Chu,
M.D., a Medical School ophthalmologist managing Rafael's eye
problems. George Hruza, M.D., a
cutaneous surgeon, treated skin
cancer on Rafael's face.
Anyone granted a look into
Juana's book would also find the
name of Rafael's roommate and
friend, a youngster who shared
25 days with Rafael in Barnard
Free Skin and Cancer Hospital.
Despite a language barrier, the
two delighted together in the
humor of the drawings in the
"Calvin and Hobbes" comic strip.
As Rafael's condition began to
respond to the collaborative
efforts of Washington University's best, he was again able to
laugh at the escapades of the boy
and his imaginary pet tiger.
22

Carlos A. Perez, M.D., director of the
Radiation Oncology Center and lead
physician in Rafael's treatment that
includes many Washington University
Medical School experts.

Diagnosed at age
four, Rafael had seen
his condition
worsen; eight years
later Lima's
specialists could be
of little help.
Strictly a night person as a result
of his aversion to light, Rafael
occasionally awakened his
mother with his laughing. But
she was delighted to have her
sleep disturbed by a sound she
had heard too little of lately.
Juana's list continued to grow:
Mike, a nurse on Barnard's fourth
floor; the good people of a church
who welcomed the Figueroas
into their congregation; a local
Peruvian family whose members
helped with understanding North
American customs. And always
the doctors who assessed and
treated and explained.
4 4FTlne doors opened,"
Juana says in a tone that
-L conveys both gratitude
and awe. "Good things just keep
happening; we keep going." She is
certain that she and her son were
destined to find Mallinckrodt.

Despite the poor long-term prognosis for Rafael, she says they feel
encouraged by his recent progress.
For her, it's a miracle that Rafael
sometimes beams out a smile from
beneath the brim of his traditional Peruvian farmer's sombrero.
Perez is pleased, but not particularly surprised, at the success
he and his colleagues are having.
' 'We have a top national center
here, with the very best people
in many fields. Our reputation is
spreading beyond the Midwest.'' In
addition to Rafael, Perez recently
has treated four other patients
from outside the country, including
a cabinet member from Uruguay.
Referrals come from the many
physicians who visit here as fellows
or guest lecturers and from the
contacts made by the Mallinckrodt
staff members on their own
travels. "They find out that we
do first-rate work," Perez says.
On Rafael's twelfth birthday,
he was honored at three
separate birthday parties.
He spoke to his father, his sisters,
aunts, and cousins in Peru, and
the family shared a few happy
moments together.
On that day, too, the family
began to lay plans to relocate to
St. Louis where they have found
so much help. Difficulties in
immigrating don't worry Juana;
she has encountered greater
hurdles.
She takes life in small pieces
and says, "That was a good day.
There are good days and bad
days, but living this way we are
nearer to God. Every day is
thanks to Him. And we learn this
lesson: Have faith. God will do
the rest for you."
That said, it's clear that
Juana Figueroa's constant companions number three, not just
two. In addition to the tangible—
her son and the book of namesthere is also an abiding faith that
generates bright hope. D
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FYI
THE DIRECTOR'S
OFFICE REPORT
NEW STAFF
Jeffrey J. Brown, M.D.,
assistant professor of radiology, Division of Diagnostic Radiology
Donald E. Gayou, Ph.D.,
research associate in threedimensional imaging, Division of Diagnostic Radiology
Landis K. Griffeth, M.D.,
Ph.D., assistant professor
of radiology, Division of
Nuclear Medicine (completed
a 4-year residency in Diagnostic Radiology and Nuclear
Medicine at Mallinckrodt
Institute of Radiology)
Marshall E. Hicks, M.D.,
assistant professor of radiology, Division of Diagnostic Radiology
Peter P. Lai, M.D., Ph.D.,
assistant professor of radiology, Division of Radiation
Oncology
Francisco Li-Aravena,
M.S., research assistant in
radiation physics, Division
of Radiation Oncology
Frederick A. Mann, M.D.,
assistant professor of
radiology, musculoskeletal
section, Division of Diagnostic Radiology

Thomas K. Pilgram, Ph.D.,
research associate in threedimensional imaging, Division of Diagnostic Radiology
Ying Su, B.S., research
assistant in radiation physics, Division of Radiation
Oncology

OFF STAFF
Lynn Barrett, M.D., co-chief
resident 1987-1988, completed a 4-year residency in
Diagnostic Radiology and has
accepted a fellowship at Rush
Presbyterian, St. Luke's Medical Center, Chicago.
Inta S. Berzins, M.D., completed a 4-year residency in
Diagnostic Radiology, and
one year of training in
Nuclear Medicine and has
accepted a position as staff
radiologist at Parkland
Hospital-Southwestern
Medical Center, University
of Texas, Dallas.
Scott J. J. Evans, M.D.,
completed a 4-year residency
in Diagnostic Radiology and
has received an imaging fellowship at San Francisco
General Hospital.

Victor A. Marcial-Vega,
M.D., instructor in radiology,
Division of Radiation
Oncology

Joseph N. Fields III, M.D.,
assistant professor of radiology, Division of Radiation
Oncology, hasjoined the staff
of the Department of Radiation Oncology, Memorial
Medical Center, Springfield,
Illinois.

PaulL. Molina, M.D.,
instructor in radiology,
Division of Diagnostic Radiology (completed a 1-year
fellowship in chest radiology at Mallinckrodt Institute of Radiology)

Kevin C. Funk, M.D., completed a 4-year residency in
Diagnostic Radiology and
has entered private practice at Eastern Idaho
Regional Medical Center,
Idaho Falls.

William H. Perman, Ph.D.,
assistant professor of radiation sciences in radiology,
Division of Radiation
Sciences

Charles F. Garvin, M.D.,
instructor in radiology,
completed a 2-year fellowship in neuroradiology and
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has entered private practice at St. Luke's Hospital,
St. Louis.

has entered private practice in Northhampton,
Massachusetts.

James R. Geurin, M.D.,
completed a 4-year
residency in Radiation
Oncology which included
one year as an American
Cancer Society Clinical Fellow and has entered private
practice with Radiation
Oncologists, Inc., Kansas
City, Kansas.

DebraD. Rosenthal, M.D.,
completed a 4-year
residency in Diagnostic
Radiology, and one year of
training in Nuclear Medicine and pediatrics, and has
entered private practice at
St. John's Mercy Medical
Center, St. Louis.

David C. Hardy, M.D.,
assistant professor of radiology, Division of Diagnostic Radiology, has entered
private practice in mammography and abdominal
and skeletal imaging at LDS
Hospital, Salt Lake City.
Howard C. Hutt, M.D.,
instructor in radiology,
completed a 1-year fellowship in neuroradiology.
Scott N. Nadel, M.D., chief
resident in radiology
1987-88, completed a
4-year residency in Diagnostic Radiology and has
entered private practice in
Bradenton, Florida.
David N. Rabin, M.D.,
instructor in radiology,
completed a 1-year fellowship
in abdominal radiology and
has accepted a position as
attending radiologist in
imaging at Rush Presbyterian, St. Luke's Medical
Center, Chicago.
Threasa A.H. Reiman,
M.D., instructor in radiology,
completed a 4-year residency in Diagnostic Radiology
and a 1-year abdominal
radiology fellowship, and
has entered private practice with Valley Radiologists
Ltd., Phoenix.
David L. Rifkin, M.D.,
assistant in radiology, has
completed seventeen months
of training in the Division
of Nuclear Medicine and

Thomas E. St. Amour, M.D.,
completed a 4-year residency in Diagnostic Radiology
and has entered private
practice with Radiology
Associates, Little Rock,
Arkansas.
Vythialingam
Sathiaseelan, Ph.D., assistant professor of radiation
physics in radiology, Division
of Radiation Oncology, has
entered private practice at
Northwestern Memorial
Hospital, Chicago.
David H. Schmidt, M.D.,
completed a 4-year residency in Diagnostic Radiology
and has received an imaging fellowship at the
University of California,
San Diego.
Clement C. Wen, M.D.,
instructor in radiology,
completed a 2-year fellowship in neuroradiology and
has entered private practice in Baton Rouge.
Xingren Ying, Ph.D.,
research associate in radiation physics, Division of
Radiation Oncology, has
accepted a position at the
Institute of Automation,
Chinese Academy Sciences,
Beying, People's Republic
of China.
Frederick R. Zivnuska,
M.D., instructor in clinical
radiology, has entered private practice in radiation
oncology at St. Luke's
Hospital, Milwaukee.
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FYI
THE DIRECTOR'S
OFFICE REPORT
FIRST YEAR
POSTGRADUATES
Jeffrey L. Borders, M.D.,
Ph.D., graduated from Cal
Tech with a Bachelor of
Science degree in biology.
Borders received his Ph.D.
in bioengineering and his
medical degree from the
University of California,
San Diego.
Edith H. Rang, M.D.,
graduated from Brown
University with a Bachelor
of Arts degree in human
biology and received her
medical degree from the
University of Pennsylvania.
She is a member of AOA.

if;

Andrew B. Landes, M.D.,
graduated from Wesleyan
University with a Bachelor
of Arts degree in chemistry
and completed his medical
education at Washington
University School of
Medicine.
Mark May hie, M.D.,
graduated from Seattle
Pacific University with a
Bachelor of Science degree
in engineering science.
Mayhle received his Master
of Science degree in chemical engineering and his
medical degree from the
University of Washington.
He is a member of AOA.
Ronald O. Robison, M.D.,
received a Bachelor of Science degree in biology and
general science from Oregon
State University and completed his medical education
at the Oregon Health Sciences University. Robison is
a member of AOA.

Robert M. Smith II, M.D.,
Ph.D., graduated from
Florida State University with
a Bachelor of Science degree
in physics and a Ph.D. in
molecular biophysics. He
received his medical degree
from Emory University.
Jonathan C. White, M.D.,
Ph.D., received a Bachelor
of Science degree in physics
and math from MIT. White
received his Master of Science degree and Ph.D. in
physics as well as his medical degree from Stanford
University.

NEW FELLOWS
KarenS. Baker, M.D.,
instructor in radiology, is a
fellow in musculoskeletal
radiology. She received a
Bachelor of Science degree
in biology and her medical
degree from the University of
Kentucky. Baker completed
her diagnostic radiology residency at the Medical College of Virginia, Richmond.
Elvira V. Lang, M.D.,
instructor in radiology, is a
fellow in interventional
radiology. Lang received her
medical degree, completed
her residency in radiology,
and was a faculty radiologist
at the School of Medicine,
University of Heidelberg,
West Germany. In the United
States, Lang completed a
radiology internship and a
fellowship in angiography
as well as a residency at the
University of California,
San Diego.

Cheryl L. Sisler, M.D.,
instructor in radiology, is a
fellow in pediatric radiology.
She received a Bachelor of
Science degree in pharmacology at the University of
Wisconsin-Madison and completed her medical education at St. Louis University.
Sisler completed her residency in diagnostic radiology at Jewish Hospital. She
is a member of AOA.
Carol K. T&tes, M.D.,
instructor in radiology, is a
fellow in abdominal radiology. She received her medical education at University
of Oklahoma Health Sciences
Center and completed her
residency in diagnostic
radiology at Baptist Medical
Center, Oklahoma City. She
is a member of AOA.

FIRST YEAR
RESIDENTS
Clinton M. Anderson, M.D.,
received his Bachelor of
Arts degree in biology from
the University of Tennessee.
He completed his medical
education and internship at
Vanderbilt University,
Nashville. Anderson is a
member of AOA.

Jamie T. Surratt, M.D.,
received a Bachelor of Science degree in physical therapy from the University of
Kentucky. She completed
her medical education at
the University of Louisville,
Kentucky, and completed
her internship and a 1-year
residency in internal medicine at Barnes Hospital.
Surratt is a member of AOA.
O. Clark West, M.D., com
pleted his premedical training at Drake University. A
1986 graduate of Washington University School of
Medicine, West completed
his internship and a 1-year
residency in internal medicine at Barnes Hospital. He
is a member of AOA.
Kris J. Van Lorn, M.D.,
graduated from the University of Oregon with a Bachelor of Arts in biology and
received his medical degree
from the Oregon Health Sciences University School of
Medicine. He completed his
internship at Mercy Hospital, San Diego, and a 3-year
diagnostic radiology residency at University of
California, San Diego. He is
a member of AOA.

William G. Horstman, M.D.,
received his Bachelor of
Science degree in chemistry
from the University of South
Dakota. A 1983 graduate of
Washington University
School of Medicine,
Horstman completed his
internship and two years of
residency in urology at the
Naval Hospital in San Diego.
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RADIATION
ONCOLOGY
RESIDENTS

NUCLEAR
MEDICINE
TRAINEES

Avraham Eisbruch, M.D.,
received his medical degree
and completed his internal
medicine residency at TelAviv University, Israel. He
completed a fellowship in
medical oncology at University of Texas and in
oncology and radiation
therapy at Tel-Aviv
University.

Farrokh DehdashtiShahrokh, M.D., received
her medical degree from
Pahlavi Medical School,
Shiraz, Iran, had an internship and three years of
radiology residency in Iran,
and completed a 2-year residency in nuclear medicine
at the Medical College of
Wisconsin Hospitals.

Martin Keisch, M.D.,
received his Bachelor of
Science degree in biology
from State University of
New York at Stony Brook
and his medical degree
from Tufts University,
Boston, Massachusetts.
Keisch completed his
internship at the Boston VA
Medical Center and is a
member of AOA.

Tsuneo Hirano, M.D.,
received his medical training
at the Gunma University
School of Medicine, Japan,
and completed his radiology residency at Tulane
University Medical Center
Hospital, New Orleans.

Jeff M. Michalski, M.D.,
received his premedical
training at the University of
Wisconsin and completed
his medical education at
the Medical College of
Wisconsin. He completed
his internship and one year
of residency in radiation
oncology at ColumbiaPresbyterian Medical
Center, New York.
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Kenneth J. Lee, M.D.,
received his B.S. and M.B.
degrees in medicine and
surgery from the University
of Melbourne, Australia. He
received the Fellow degree
in internal medicine and
cardiology from the Royal
Australasian College of
Physicians.
JeroldL. Saef, M.D.,
received his Bachelor of Arts
degree in chemistry from
Florida Atlantic University
and his medical degree from
the University of South
Florida College of Medicine.
He completed a 2-year
residency in cardiology and
a 3-year residency in internal
medicine at St. Elizabeth's
Hospital of Boston, an
affiliate of Tufts University
School of Medicine. Saef
has received U.S. Board
certification in internal
medicine.

VISITING PROFESSORS
& INVITED LECTURERS
Louis A. Gilula, M.D., professor of radiology, attended
the National Podiatric Association, Anaheim, August 19.
Gilula lectured on "Musculoskeletal Neoplasia" and
' Arthrography/Tenography
of Foot and Ankle." He
attended the American
Society for Surgery of the
Hand, Baltimore, September 15. He participated in a
panel discussion on "Imaging Techniques." Gilula
attended the International
Skeletal Society, Sydney,
Australia, September 25—
October 10, where he spoke
on "Wrist Arthrography—
Update." He spoke on "CT
Bahman Emami, M.D.,
and 3-D CT of the Wrist,"
professor of radiology, pre"Analytic Approach to Carsented "Clinical Experience pal Injuries," "CT of the
with Interstitial HypertherFoot and Ankle" at Diagmia and Radiation Therapy" nostic Radiology Update,
at the Role of Hyperthermia University of Texas, Southin Radiation Oncologywestern Medical Center,
Cooperative Meeting
Dallas, October 28-30.
between the United States
Gilula was co-organizer of
and the People's Republic of an international "Wrist
China, Beijing, China,
Investigator Workshop,"
September 8-10.
and lectured on "The Wrist1988," "Radiographic AnatMokhtar Gado, M.D., proomy and Exam," "Inflamfessor of radiology, presented
mation X-Ray Exam," and he
"MR—Anatomy of the Spine
attended a panel on' 'Clinical
and Cord at the CraniocerEvaluation of the Wrist,"
vical Junction" at the XVth
Tampa, November 3-5.
Congress of the European
Society of Neuroradiology
Jay P. Heiken, M.D., assoin Wurzburg, Germany, Sep- ciate professor of radiology,
tember 13-17. Gado prepresented "MRI of the
sented "Overall Approach
Pelvis" at seminars in Magto Low Back Pain," "Princi- netic Resonance Imaging in
ples of Interpretation of MR Door County, Egg Harbor,
Images of the Brain," and
Wisconsin, July 29-31.
"Lesions of the Sellar
Region" at the 1988 Harvard
Postgraduate Course, "Current Concepts in Neuroradiology, Head and Neck Radiology, and Neuro-MRI," in
Boston, October 3-7.

James P. Crane, M.D., professor of radiology, presented Meet-the-Professor
Session on "The Fetus with
a Problem" at the AM Institute of Ultrasound in Medicine—World Federation for
Ultrasound in Medicine
Annual Meeting, Washington, D.C., October 17-21.
Crane was visiting professor at Harvard Medical
School, September 30—
October 2, where he spoke
on "Prenatal Diagnosis and
Management of Genitourinary Malformations" and
"Sonographic Diagnosis of
Neural Tube Defects."
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Andrei Laszlo, Ph.D., assistant professor of cancer
biology in radiology, lectured
on "Mechanisms of Thermotolerance: Less Damage
or Better Repair" at Stanford University, Department of Radiology, June 29;
Laboratory of Cell Biology,
Lawrence Berkeley Laboratory, July 5; Radiation
Oncology Research Laboratory, Department of Radiology, University of California,
San Francisco, July 8. Laszlo
was visiting staff scientist
at the Radiation Biology
Section of the Radiation
Oncology Branch of the
National Cancer Institute,
July 24—August 2. He visited
Beaumont Hospital and
Wayne State University in
Detroit and the University
of Michigan at Ann Arbor,
November 8—10, where he
presented a series of lectures
"On the Molecular Mechanisms of Thermotolerance."
Joseph K.T. Lee, M.D.,
professor of radiology,
chaired a scientific session
at the 7th annual scientific
meeting of the Society of
Magnetic Resonance in
Medicine, San Francisco,
August 20-26. Lee spoke at
a seminar on "Magnetic
Resonance Imaging of the
Liver and Male and Female
Pelvis" in Los Angeles,
September 16-18.
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Bruce L. McClennan, M.D.,
professor of radiology,
attended the Uroradiology
'88 conference at the University of Minnesota PGC,
Minneapolis, where he presented "Low Osmolar Contrast Media" and "Oncologic
Imaging." McClennan was
an invited speaker at the
Royal Australian College of
Radiology (RACR), Auckland,
New Zealand, October 2-7.
He also attended uroradiology meetings in Melbourne,
Australia, October 14-16,
where he was a guest lecturer. McClennan presented
"Low Osmolar Media—U.S.
Experience," "CTof the
Indeterminate or Problem
Mass," "Prostatic Ultrasound," and "Lithotripsy—
Beyond the Stone Age."
Tom R. Miller, M.D., Ph.D.,
associate professor of radiology, presented a paper
' 'Three-Dimensional Display
of SPECT Images" at the
annual meeting of the Missouri Valley Chapter, Society of Nuclear Medicine,
Des Moines, September 17.
Stephen Moerlein, Ph.D.,
assistant professor of radiation chemistry in radiology,
presented "Recent Developments in Radiopharmaceuticals for PET and
SPECT" at the Nuclear
Research Center, Juelich,
Federal Republic of Germany,
on July 12.

William A. Murphy, M.D.,
professor of radiology, spoke
as the invited education
session lecturer on "MRI of
Bone Marrow" at the midFebruary meeting in Boston
of the Society for Magnetic
Resonance Imaging. Murphy
also was invited plenary
session speaker at the
Meeting of the Society of
Magnetic Resonance in
Medicine in San Francisco,
August 20-26. The topic
was "MRI of the Bone Marrow and Musculoskeletal
Tumors." He was an invited
speaker at a conference titled
"Early Decisions in DMARD
Development" jointly
planned and co-sponsored by
the Arthritis Foundation,
the American Rheumatism
Association, the National
Institutes of Health and the
Federal Drug Administration
in Washington, D.C, September 29. The topic was
"Newer Imaging Techniques
in Proving Efficacy of Candidate Compounds." Murphy
was an invited participant at
a workshop on "Directions in
Research in Diagnostic Imaging" held by the National
Cancer Institute, WinstonSalem, North Carolina,
October 12-14. He was an
invited lecturer at continuing
education meetings on Practical Magnetic Resonance
Imaging 1988, Las Vegas,
October 21-22, where he
spoke on "MRI of Musculoskeletal Tumors," "MRI of
the Bone Marrow: Basic
Concepts," "MRI of the Bone
Marrow: Clinical Aspects."
He also spoke at the 17th
Annual Seminar Musculoskeletal Disorders, Phoenix,
November 11-13, on"MRI of
Bone Marrow," "MRI of
Musculoskeletal Tumors,"
and "Forensic Radiology."

Henry D. Royal, M.D.,
associate professor of radiology, attended Management
of Radiation Accidents,
Albuquerque, October 6-8,
where he presented "Carcinogenesis and Radiation,"
"Bone Marrow Transplantation" and "Combined Injury."
StuartS. Sagel, M.D.,
professor of radiology, was
a visiting professor at
St. Luke's/Presbyterian Hospital, Rush Medical School,
Chicago, July 15.
Barry A. Siegel, M.D.,
professor of radiology, served
on the faculty of the eleventh
annual postgraduate course
on Practical Radiology, University of Virginia School of
Medicine, Charlottesville,
Virginia, October 10-13,
where he presented lectures
on "Ventilation-Perfusion
Scintigraphy and Pulmonary
Embolism" and "Gastrointestinal Bleeding Scintigraphy."
Joseph R. Simpson, M.D.,
Ph.D., associate professor
of radiology, spoke on
"Techniques and Results of
Interstitial Implants in
Malignant High Grade Gliomas" at Tufts University,
New England Medical Center Hospitals, May 20.
Jerold Wallis, M.D., assistant professor of radiology,
attended Clinical Nuclear
Medicine Update, sponsored
by the Missouri Valley Chapter of the Society of Nuclear
Medicine, Des Moines,
September 17, where he
presented "Selection of
Optimal SPECT Reconstruction Filters."
Todd H. Wasserman, M.D.,
professor of radiology,
attended the semiannual
Cancer and Acute Leukemia
Group B Meeting in Atlanta,
October 26, where he
participated in the lymphoma, radiation, and lung
subcommittee.
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SYMPOSIA
Bahman Emami, M.D.,
professor of radiology,
attended the 5th Symposium
on Hyperthermic Oncology,
Kyoto, Japan, September
4-15. Emami presented
"Interstitial Hyperthermia
and Brachytheraphy in the
Treatment of Head and Neck
Cancer," "Thermoradiotherapy of Malignant Melanoma," and "Regional
Hyperthermia in the Treatment of Recurrent DeepSeated Tumors: Analysis of
Phase I Trial." He attended
the first annual Oncology
Symposium: Non-Small Cell
Lung Cancer, Kansas City,
November 18, where he
presented "Radiotherapeutic
Management of Non-Small
Cell Lung Cancer."
Andrei Laszlo, Ph.D.,
assistant professor of cancer
biology in radiology, attended
the 5th International Symposium on Hyperthermic
Oncology, Kyoto, Japan,
August 29—September 3.
He presented a poster titled
"Mechanisms of Thermotolerance: Less Damage or
Better Repair?" and a paper
on ' 'Modifications of Various
States of Thermotolerance"
in the workshop on "Modification of Thermotolerance" and a paper on
"Mammalian Heat Shock
Proteins: The Search for
Functions." Laszlo was also
invited to speak at a satellite meeting on "Heat
Shock Proteins" at Kyoto
University, September 5,
where he presented a talk
entitled "Mammalian Heat
Shock Proteins."
Stuart S. Sagel, M.D., professor of radiology, presented
"CT of the Mediastinum'' and
"CT of the Pleura" at the
Ninth Annual Brown University Symposium on Diagnostic Imaging, Newport,
Rhode Island, August 8-11.

Gilbert H. Nussbaum,
Ph.D., associate professor
of radiation physics in radiology, attended the 5th
International Symposium
on Hyperthermic Oncology
in Kyoto, Japan, August 29—
September 3. At this meeting
he organized and co-chaired
a symposium session,
"Techniques for Electromagnetic Heating," and
presented a paper titled
"Targeted Deep Heating
through Manipulation of
SAR Distributions." He also
attended the U.S./China
Cooperative Meeting on
"The Role of Hyperthermia
in Radiation Oncology,"
Beijing, People's Republic of
China, September 8-10,
where he co-chaired the
opening session on "Hyperthermia Physics, Engineering, and Thermometry," and
presented a paper titled
"Directed Deep Heating."
Joseph L. Roti Roti, Ph.D.,
professor of cancer biology in
radiology, chaired two sessions at the 5th International
Symposium on Hyperthermic
Oncology, Kyoto, Japan,
August 27-September 3. The
subject of the first session
was "Heat Induced Changes
in Nuclear and NuclearMatrix Protein" co-authored
with Andrei Laszlo, Ph.D.,
and the second session was
"The Effects of Hyperthermia on DNA Damage and
Its Repair." Roti Roti
presented a paper entitled
"Heat-Induced Changes in
the Protein Content of Nuclei
and Nucleoids as Modified
in Thermotolerant Cells by
Procaine, Ethanol or Glycerol" co-authored with
Nazan Turkel.

Jeffrey J. Brown, M.D.,
assistant professor of radiology, presented "History of
MRI" at a symposium titled
"Application of High Technology to Medical Care" at
the University of California
School of Medicine, San
Diego, September 13.
Judy M. Destouet, M.D.,
associate professor of radiology, presented "Mammography and the Augmented
Breast" at the Third
Annual Plastic Surgery of
the Breast Symposium,
Santa Fe, September 7.
Carlos A. Perez, M.D.,
professor of radiology and
director of the Division of
Radiation Oncology, spoke on
"Controversies in the Role
of Radiation Therapy in the
Management of Cervical
Metastatic Lymph Nodes in
Tumor of the Oral Cavity,
Oropharynx and Larynx"
at the Second International
Conference on Head and
Neck Cancer, July 31—
August 5, Boston. Perez
attended the 5th International Symposium on Hyperthermic Oncology, Kyoto,
Japan, August 29—September 3, where he spoke on
"Prognostic Factors in the
Combined Treatment of
Tumors Radiation Dose and
Fractionation," "Irradiation
and Hyperthermia in the
Treatment of Recurrent
Carcinoma of the Breast in
the Chest Wall," "MIR and
RTOG Experience," and
"Irradiation and External
Hyperthermia in Treatment
of Head and Neck Cancer."
He also spoke on "Hyperthermia in the Treatment of
Cancer," "Cancer of the
Lung," "New Techniques of
Irradiation," and "Radiation
Therapy in Head and Neck
Cancer," Medellin, Colombia,
at the 10th Anniversary
Instituto de Ciencias de la
Salud, September 14-16.

AMERICAN
SOCIETY FOR
THERAPEUTIC
RADIOLOGY AND
ONCOLOGY
The following Mallinckrodt Institute staff members participated in the
30th Annual Scientific
Meeting of the American
Society for Therapeutic
Radiology and Oncology,
New Orleans, October 9-14.

SCIENTIFIC
SESSIONS
Bahman Emami, M.D.,
organized and moderated
"Photon Three-Dimensional
Treatment Planning." He
also presented "Three
Dimensional Treatment
Planning for Lung Cancer"
and "3-D Planning in
Thoracic Oncology!'
James A. Purdy, Ph.D.,
organized and moderated
"Electron Beam Dosimetry." He also presented
"The Use of Dose Surfaces
for Three-Dimensional
Treatment Planning'.'
John W. Wong, Ph.D., presented "On-Line Radiotherapy Imaging with an Array
of Fiber-Optic Image
Reducers" and "Patient
Dose Estimation Using
Entrance and Portal Dose
Distributions!'
Joseph R. Simpson, M.D.,
Ph.D., moderated "Radiation Therapy Oncology Group
(RTOG) Survival Data on
Anaplastic Astrocytomas of
the Brain: Does a More
Aggressive Form of Treatment Adversely Impact Survival?" He also presented
"Three-Dimensional Treatment Planning Considerations for Prostate Cancer!'
Todd H. Wasserman, M.D.,
moderated "Biology of
Sensitize rs!'
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SYMPOSIA HONORS/
AWARDS

MartinS. Weinhous, Ph.D.,
presented "On a More Efficacious Presentation of the
Images Used in Radiation
Oncology"

SCIENTIFIC
EXHIBITS
James A. Purdy, Ph.D.,
"Three Dimensional Radiation Therapy"

REFRESHER
COURSES
Bahman Emami, M.D.,
"Applied Techniques and
Clinical Practice of Interstitial Hyperthermia" and
"Three-Dimensional Treatment Planning for Lung
Cancer"

James P. Crane, M.D.,
professor of radiology, was
named recipient of the
Virginia Lang Chair in
Obstetrics and Gynecology,
August 8.
Andrei Laszlo, Ph.D.,
assistant professor of radiology in cancer biology,
attended the 5th International Symposium on
Hyperthermia Oncology in
Kyoto, Japan, as one of
seven recipients of the Outstanding Young Investigators in Hyperthermia award
sponsored by the Yamamoto
Vinyter Company of Japan.
Barry A. Siegel, M.D.,
professor of radiology,
received a grant from the
Edward Mallinckrodt, Jr.
Foundation to research coronary artery disease using
Positron Emmission Tomography. Coinvestigators are
Mark A. Mintun, M.D.,
assistant professor of radiology, and Robert J. Gropler,
M.D., instructor in radiology.

APPOINTMENTS/
ELECTIONS
Andrei Laszlo, Ph.D.,
assistant professor of cancer
biology in radiology, was
appointed a representative
for the program committee of
the 1989 national meeting of
the North American Hyperthermia Group in Seattle.
Bruce McClennan, M.D.,
professor of radiology, was
invited to join the ACR Intersociety Committee on Systematized Refresher Courses
as co-chairman of the Subcommittee on Genitourinary
Radiology. The subcommittee
will develop plans for a genitourinary radiology course
for the 1989 meeting in
New Orleans of the American Roentgen Ray Society
and future refresher courses
in genitourinary radiology.
TomR. Miller, M.D., Ph.D.,
associate professor of radiology, was elected presidentelect of the Computer and
Instrumentation Council,
Society of Nuclear Medicine.

TECHNOLOGIST NEWS
Norman L. Hente, R.T., B.S.,
FASRT, was conference
coordinator and Murray
Lecturer for the 56th
Annual Conference of the
Missouri Society of Radiologic Technologists.
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William A. Murphy, Jr.,
M.D., professor of radiology,
was appointed to a threeyear term on the Scientific
Program Committee of the
American Roentgen Ray
Society. Murphy is also currently serving on the Scientific Program Committee of
the Radiological Society of
North America as chairman
of the Skeletal Committee.
Gilbert H. Nussbaum,
Ph.D., associate professor
of radiation physics in radiology, was a member of the
thesis examination committee for S.G. Kim of the
Department of Chemistry, for
his dissertation on "A deuterium nuclear magnetic resonance spectroscopic investigation of tumor blood
flow in-vivo" August 18.

ALUMNI
NEWS
Norbert J. Liebsch, M.D.,
Ph.D., has accepted a staff
position in Therapeutic Radiology working on the Proton
Beam Project at Massachusetts General Hospital.
After completion of his residency in Diagnostic Radiology at the Institute, Liebsch
finished his training in
Therapeutic Radiology at
the Mayo Clinic. He received
certifications in Diagnostic
Radiology and Therapeutic
Radiology by the American
Board of Radiology and is currently applying for his Massachusetts medical license.
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FYI
CIC
NEWS
The Cancer Information
Center (CIC) is cosponsored
by the Mallinckrodt Institute of Radiology and the
Barnard Free Skin and
Cancer Hospital at the
Washington University
Medical Center.

CONTRIBUTIONS
Mr. and Mrs. Herbert R.
Bilgram in memory of Alma
Arnold
Power and Grounding
Department of AT&T in
memory of Caladonia Roberts
Mrs. Marilyn Busch in memory of Adolph Sherman
Mr. & Mrs. Donald Speraneo
in memory of Elsie Ferguson
Mr. Edwin B. Beissner, Jr. in
memory of A. Wessel
Shapleigh
Dr. Gerald La Marsh in
memory of Connie Foley
Mr. & Mrs. Roy E. Lenox in
memory of Connie Foley
Mr. & Mrs. Roy E. Lenox in
memory of Rudy
Schnurbusch
Mr. & Mrs. Frederick
Hermann in memory of Nan
Jones
Social Services NW &
Adolescent Psych Unit in
memory of Noel Miller
Mr. & Mrs. R. B. Thomas in
memory of Dr. Robert
McKibbon
U.S. Army AVSCOM in
memory of Lewis Jones
Daniel P. Schrage in memory of Dr. Lewis L. Feaster
Anthony M. Corgiat in
memory of Dr. Lewis L.
Feaster
Miss Shirley Germaine in
memory of Mrs. Barbara
Buford
Sylvia Schacter in memory
of Louis Kootman
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Van H. Hale in memory of
Connie Foley
Mr. & Mrs. G.E. Ingram in
memory of Connie Foley
Peggy Layman & family,
Denise Rodamich, Jean
Stoner, Sandra Reed in
memory of Darryl Matlock
Mr. & Mrs. Adrian O. Levin
in memory of Tony Halinski
Helen M. Carter in memory
of Janice Sue Beeler
Emilie A. Beeler in memory
of Janice Sue Beeler
Mr. & Mrs. Sidney Bronfin
in memory of Barbara L.
Wegmann
Mr. & Mrs. Sanford J.
Kornbery in memory of
Connie Foley
Mr. & Mrs. H.J. Wakeling in
memory of Connie Foley
Mr. & Mrs. Clede Slade and
Joan in memory of Mike Karr
Mr. & Mrs. Paul A. Comer in
memory of Morty Bibb
Julia F. and John Yarbrough
for Mrs. Dexter Farnsworth
and Dexter Farnsworth
Mrs. L.G. Kellerman in
memory of Connie Foley
Mr. & Mrs. Anthony DeBasio
in memory of Calvin Owens
Mrs. Karen C. Bizzell
Dr. Deborah C. Love in
memory of Connie Foley
Mrs. Ward M. Miller, Jr. in
memory of Connie Foley
Nicoline F Mix in memory
of Connie Foley
Mr. & Mrs. Charles Stoops in
memory of Connie Foley
Kutis Bowling League, Red
Bird Lanes in memory of
James Illert
Ms. Mary F. Saf ron in memory of Dorothy Schwartzman
Mrs. Dora D. Thompson in
memory of Bene B. Hinsman
Staff of 5400, Barnes
Hospital Plaza in memory
of brother of Carmeletta
Calhoun

"Tucker's Place", Kathy,
Cindy, Rhonda, Gloria and
Jerry in memory of
Dr. Joseph Jaudon
Marie Brettschneider
Judy C. Hunt in memory of
Lester Whited
Mr. & Mrs. Sidney J. Bronzin
in memory of Lenore S. Rosen
Sandy Wood in appreciation
of the thoughtfulness of
Susie Yawitz
Mr. & Mrs. William J.
Kristen, Jr. in memory of
Preston Harrison and
Patricia Parker
Sylvia Schacter in honor of
wedding anniversary of Mr.
& Mrs. George Lamb
Daniel Miller-for the family
and friends of Susan Miller
Gennari in memory of
Susan Miller Gennari
Judy C. Hunt in memory of
Lester Whited
Lloyd Jacobs
Mrs. Dorothy Showman in
memory of Jarold E.
McFarland
Mr. & Mrs. Everett Siegel in
memory of Kenneth Lever
The Lab of 5509 Wohl
Hospital in memory of
Fannie Barker
Mrs. J.E. Kellogg in memory
of Connie Foley
Mrs. FA. Hone in memory
of Connie Foley
Susan M. Huch in memory
of Connie Foley
Aleta Kyle in memory of
Mark Woods
Dorothy Weiss in memory
of Mark Woods
Victor and Jean Arnold in
memory of Mark Woods
T Gaynor Blake in memory
of John Hillmeyer
Helen R. Taylor in memory
of Joseph B. Batha
Mr. & Mrs. Carl Mounce in
memory of Lena LaFiore
Mr. & Mrs. Walter Werner in
memory of William Scheper

Donna Freeman
KSDK donation in tribute
of Dr. Judy Destouet
Mr. & Mrs. James Garlanddonation
Helen R. Sproull in memory
of Beau Peters
Miriam M. Rand in memory
of Beau Peters
Crystal S. Heifner in
memory of Beau Peters
Ida Speranes in memory of
W.C. Morris
Mr. & Mrs. Sidney Bronfin
in memory of Sylvia Rosen
Mr. & Mrs. Wilbert Beshore
in memory of Mike Niznik
Mr. & Mrs. Richard Pelot in
memory of Mrs. Nancy Hall
Opal and Sharon Alles in
memory of Dave Brumlet
Mrs. A. J. MacDonald in
memory of Georgia Lewis
Mr. & Mrs. Merle J. Anker in
memory of Max Kleiman
Mr. & Mrs. Frederick
Hermann in memory of
Mary Bowman Peters
SLDDTC, OT & PT Staff and
Services in memory of
Joseph Garavaglia
Mr. & Mrs. R.J. Collins in
memory of George Skinner
Verna Ruzicka in memory
of Leonard J. Mandeville
Debbie Schachter and family
in memory of Matthew
Mueller
Debbie Schachter and family
in memory of Ann Roy
Erma Jean Bullerdick in
memory of Mr. Aylward
Sylvia Schacter in memory
of Mary Jones
Mr. & Mrs. R.F Collins in
memory of Beau Peters
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CALENDAR
December 12, 1988
City-Wide Radiology
Conference
MRI in the Clinical Management of Lymphoma
Elias A. Zerhouni, M.D.
professor of radiology
Johns Hopkins Medical
Center, Baltimore
Scarpellino Auditorium
January 9, 1989
City-Wide Radiology
Conference
St. Louis University
To Be Announced
February 13, 1989
City-Wide Radiology
Conference
"MRI of the Pelvis: Staging
and Monitoring Response
Time in Therapy"
Herbert H. Kressel, M.D.,
professor of radiology
Hospital of the University
of Pennsylvania,
Philadelphia
Scarpellino Auditorium
March 13, 1989
City-Wide Radiology
Conference
3rd Annual Daniel R. Biello
Memorial Lecture
"Issues Facing the Diffusion
of Medical Technology"
Barbara J. McNeil, M.D.,
professor, radiology &
clinical epidemiology
Harvard Medical School,
Boston
Scarpellino Auditorium
April 10, 1989
City-Wide Radiology
Conference
Leroy Sante Lecture
St. Louis University
To Be Announced
May 8, 1989
City-Wide Radiology
Conference
"Stereotactic Breast Biopsy'
Judy M. Destouet, M.D.,
associate professor of
radiology
Mallinckrodt Institute of
Radiology
Scarpellino Auditorium
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The BBC's Sir David
Attenborough recently
traveled to Mallinckrodt Institute with a full crew to film a
program concerning the
modern study of fossils. Here,
Sir David confers with
Michael W. Vannier, M.D.,
associate professor of radiology and director of the image
processing laboratory.
Washington University Medical School's Glenn Conroy,
Ph.D., points out a detail on
the CRT for the camera.

Also visiting Mallinckrodt
this fall was world-famous
still photographer Alexander
Tsiaras. Working for LIFE
Magazine and a consortium of
foreign publications, Tsiaras
trained his eye on the manner
in which radiology is aiding
craniofacial reconstructions
andpediatric heart surgery.
Here, he focuses on an infant
5 in a CT scanner's bore.
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SPOTLIGHT
PROFILES OF THE CHIEFS

JOHN ENGELS
John Engels, M.D., has come
to know precisely what he
wants. His technique has been
to experiment and then rule out
that which he does not like. Now
chief resident in Diagnostic Radiology at Mallinckrodt Institute of
Radiology and liking it, Engels
describes the process he's been
through as "constantly redefining what is personally and
professionally satisfying."
Reassessing his directions
hasn't always been easy, but
Engels has been decisive and
unwilling to settle for less than
the best. The son of a Chicago
psychiatrist, he earned an undergraduate degree in science educaton at the University of Illinois,
Champaign-Urbana, after the
"hubbub" of medical school put
him off initially. And he taught
science on the north side of
Chicago for a year before he realized that the unstable work environment for teachers in the late
'70s, with enrollments down,
meant an employment insecurity
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he could not tolerate.
So Engels worked for a year
as a research technician in cellular immunology, then moved on
to graduate school in the same
field. Eventually, his testing of
the prevailing circumstances led
to the realization that complete
professional satisfaction lay only
in a career as a physician.
Chicago's Rush Medical College proved fulfilling, and Engels
followed with an internship in
internal medicine at Washington
University, coming here first in
1984. From that experience, he
learned that the peculiar demands
of 24-hour-a-day patient care
were not for him. "The abstract
is more my style," Engels says,
though he still gets plenty of
patient interaction.
For a time, he thought about
following his father into psychiatry, but radiology kept beckoning. Although he says he's not
"particularly oriented toward
the technology," he's still confident of his choice of a career in
radiology. The greatest reward
has been to "know the diseases,
what causes them, and how to
recognize them." The challenge
of correlating what the films
show with a patient's history and
symptoms clearly pleases Engels.
He'll continue to explore that
challenge when he completes his
residency in 1989, then enters
private practice with a group of
Mallinckrodt alumni at St. Louis'
Missouri Baptist Hospital. "It's a
general practice; we'll see it all,"
he says with anticipation.
John Engels has known for a
long time that he was headed into
private practice. That decision,
along with those that came before
it and those being pondered today,
was made only after he tested
the waters. When he didn't like
something, he looked for another
answer. Imagining a more appropriate mindset for a diagnostic
radiologist is difficult. D

BRUCE BOWER
The conventional path to the
practice of radiologythrough college, medical
school, internship, and residency
—may have become more the
exception than the rule. Witness
Bruce Bower, M.D., new co-chief
resident in Diagnostic Radiology
His medical education began with
an early commitment to a six-year
program through which he earned
both B.S. and M.D. degrees.
Bower is not sure what the B.S. is
in. "It was the M.D. I was after,"
he says with characteristic
pragmatism.
Bower's education has also
continued longer than most,
including a three-year residency
in internal medicine and four
years as a resident in radiology.
His plans call for an additional
year to be devoted to a fellowship in interventional radiology
with Daniel Picus, M.D., here at
Mallinckrodt before he calls his
formal education complete.
Though Bower knew early that
his professional life would be
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spent in some type of service to
others, it was an event late in
high school that set his course
into medicine. Over the summer
months, Bower and some friends
worked at painting houses, and a
member of the crew was involved
in a serious motorcycle accident
on his way home from work one
day. Bower visited that friend
during his convalescence and
recognized in the medical profession the opportunity to combine
many of his interests. As an
aside, he notes that the accident
victim is also a physician today,
just back in this country after
three years of service as a missionary in Africa.
During medical training at
Hahnemann University in Philadelphia and his internal medicine
residency at Case Western Reserve,
Bower discovered that he was
' 'always interested in the new
things going on in the basement."
New CT technology, the emergence
of MRI, and the development of
interventional techniques lured
him away from internal medicine. Interventional radiology
suits him especially well because,
"I get restless reading films all
day. I like to work with my
hands, do procedures, and interact directly with patients."
Away from the many hours
he gives to the work each week,
a high level of activity remains
characteristic of Bower, who is
single. He works out and plays
racquetball, tennis, and touch
football. He also contributes to
Mallinckrodt's Softball team, for
which he often pitches. "Unless
Ron (Evens) shows up. Then he's
the pitcher. Unless he says I'm
the pitcher."
When his residency and the
fellowship to follow end, Bower
foresees private practice, "probably in Colorado, but maybe back
in Pittsburgh." His mildly unconventional path to his goal has not
cost him any of his pragmatism.
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"I'll try to get the best job in the
nicest area I can," he says. □

RICHARD LOVETT
Richard Lovett, M.D., paid
his way through the University of Vermont by working in the fire department of his
hometown, answering the fire
alarm. Now that Lovett is the new
assistant chief resident in Radiation
Oncology at Mallinckrodt, he has
traded the fire bell for a beeper,
but he's still on call.
Lovett doesn't mind. He
answers the beeper's signal many
times during the course of a day
that usually runs to 15 hours,
sometimes more now that he's
studying for boards. For Lovett,
it's all satisfying; "everything I
hoped for," he says.
Life as a physician always
appealed to him, but "the road
looked very long" when he first
entered college. Anxious to get out
on his own, Lovett undertook a
two-year course of study that
earned an Associate's Degree as a
nuclear medicine technologist. He

spent the next three years pursuing
that career at New England
Deaconess Hospital in Boston.
"But there are only so many
career paths open to a technologist," Lovett says. He knew he
wanted to continue working with
patients, so he went to medical
school. The same interest in technology that had drawn him to
nuclear medicine made radiology
a natural choice as a specialty.
And a rotation in oncology in
Vermont demonstrated just how
he could blend his love for
physics and the scientific with
his desire to care for patients.
Many of Lovett's patients are
very ill, some of them terminally
so. "That's sometimes difficult,"
he admits. "When you treat someone for weeks on end, you develop
an attachment. But no matter
what the outcome, you're doing
your best to either cure them or at
least make them more comfortable." Lovett reduces the issue to
its basics and explains, ' 'They
need something from me. I help."
He is the first in his family to
leave Vermont in the pursuit of
his profession. Two sisters remain
within 20 miles of the family home,
and a brother followed a family
tradition and became a firefighter
with the Rutland department.
The move to Missouri has been a
step into a more conservative
realm—politically and socially—
but not an unpleasant experience
for Lovett who says he has
"found a niche."
All of his work has been in
academic departments, and Lovett
anticipates that when he leaves
Mallinckrodt after next year as
chief resident, he will continue
to mix research, writing, and
clinical work. Exactly where,
though, he's not sure. "I have no
idea where I'll go," he says.
Wherever it is, he'll remain on call
in the service of his patients. □

MALLINCKRODT INSTITUTE OF RADIOLOGY

When magnetic resonance imaging (MRI) focuses on one "slice" of the anatomy,
it actually makes three images. Diagnosticians study all three, comparing
them to what they know to be normal. Lately, in Mallinckrodt's image processing laboratory, each of the three has been assigned a color, and then they've
been combined. According to neuroradiologist Mokhtar Gado, M.D., the colorization makes the components distinct and suggests ways in which tissues are
either similar or different. "This is just the beginning, though," Gado says.
"We still have many questions." Here, the process has been applied to MRI
images ofapatient's spinal cord, brain stem, and cerebellum. Note that subcutaneous fat and bone appear similar in color. Gado says that result is due to
the presence of high fat content marrow within the bone.
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